Publications by authors named "Boris Mathys"

Claim this Profile
N
Novel S1P1 receptor agonists - Part 4: Alkylaminomethyl substituted aryl head groups.
Cyrille Lescop, Claus Müller, Boris Mathys, Magdalena Birker, Ruben de Kanter

Eur J Med Chem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel S1P(1) receptor agonists--part 2: from bicyclo[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes.
Martin H Bolli, Jörg Velker, Claus Müller, Boris Mathys, Magdalena Birker

J Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel S1P(1) receptor agonists--part 3: from thiophenes to pyridines.
Martin H Bolli, Stefan Abele, Magdalena Birker, Roberto Bravo, Daniel Bur, Boris Mathys

J Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes.
Martin H Bolli, Claus Müller, Boris Mathys, Stefan Abele, Magdalena Birker

J Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
Martin H Bolli, Stefan Abele, Christoph Binkert, Roberto Bravo, Stephan Buchmann, Boris Mathys

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.
Martine Clozel, Christoph Binkert, Magdalena Birker-Robaczewska, Céline Boukhadra, Shuang-Shuang Ding, Boris Mathys

J Pharmacol Exp Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis